Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019

BACKGROUND: Sites of entry for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly expressed in nasal epithelial cells; however, little is known about the impact of intranasal corticosteroids (INCS) on coronavirus disease 2019 (COVID-19)-related outcomes. OBJECTIVE: To determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauss, Ronald, Jawhari, Nesreen, Attaway, Amy H., Hu, Bo, Jehi, Lara, Milinovich, Alex, Ortega, Victor E., Zein, Joe G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381621/
https://www.ncbi.nlm.nih.gov/pubmed/34438103
http://dx.doi.org/10.1016/j.jaip.2021.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381621/
https://www.ncbi.nlm.nih.gov/pubmed/34438103
http://dx.doi.org/10.1016/j.jaip.2021.08.007

Ejemplares similares